Back to Search
Start Over
Higher Risk of Dyslipidemia With Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide than Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate Among Antiretroviral-Naive People Living With HIV in China.
- Source :
- JAIDS: Journal of Acquired Immune Deficiency Syndromes; Oct2022Supplement, Vol. 91, pS8-S15, 8p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 15254135
- Volume :
- 91
- Database :
- Complementary Index
- Journal :
- JAIDS: Journal of Acquired Immune Deficiency Syndromes
- Publication Type :
- Academic Journal
- Accession number :
- 159061700
- Full Text :
- https://doi.org/10.1097/QAI.0000000000003040